Bart Metselaar is an author at University of Twente specializing in atherosclerosis, tumor microenvironment, and cardiovascular disease.
Top concepts
MedicineOncologyPathologyImmunologyPhysiologyNanomedicinePharmacologyImmunotherapyPublic HealthDrug Discovery
Publications per year
1975–2016
2
2
Liposomal doxorubicin: the good, the bad and the not-so-ugly
János Szebeni, Tamás Fülöp, László Dézsi et al. · Journal of drug targeting · 2016 · 15 citations · Full text
Rows per page
1–2 of 2